NASDAQ:NH NantHealth (NH) Stock Price, News & Analysis $0.02 0.00 (0.00%) (As of 09/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSustainabilityTrends Get NantHealth alerts: Email Address About NantHealth Stock (NASDAQ:NH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NantHealth alerts:Sign Up Key Stats Today's Range$0.02▼$0.0250-Day Range$0.00▼$0.0352-Week Range$1.24▼$9.75Volume734 shsAverage Volume38,073 shsMarket Capitalization$154,060.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.Read More… Forget Trump and Kamala (Ad)I hope you're deleting all those emails telling you how to make "1,000% gains" from the magic "Kamala Trade". It's nonsense. No one knows what's going to happen in November.THIS CALENDAR is the only thing that matters for you and your financial health right now. NantHealth Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 12th PercentileNantHealth scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for NantHealth.Read more about NantHealth's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NantHealth is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NantHealth is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for NH. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNantHealth does not currently pay a dividend.Dividend GrowthNantHealth does not have a long track record of dividend growth. Sustainability and ESG4.3 / 5Environmental Score-0.69 Short InterestThere is no current short interest data available for NH. News and Social Media1.0 / 5News Sentiment-0.18 News SentimentNantHealth has a news sentiment score of -0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for NantHealth this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, NantHealth insiders have not sold or bought any company stock.Percentage Held by Insiders61.30% of the stock of NantHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 4.50% of the stock of NantHealth is held by institutions.Read more about NantHealth's insider trading history. Receive NH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NH Stock News HeadlinesNew Hampshire boy, 11, trapped between boulders freed after 9-hour ordealSeptember 18 at 10:11 PM | nypost.comStockNews.com Begins Coverage on NantHealth (NASDAQ:NH)September 16, 2024 | americanbankingnews.comMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a row! But – knowing what the options trading landscape looks like, and what you're up against is a must.September 20, 2024 | Unstoppable Prosperity (Ad)NantHealth Welcomes Scott Maratea as Chief Revenue Officer to Executive TeamAugust 28, 2024 | tmcnet.comNew Hampshire challenges "unjust" Massachusetts gun laws over impact on residents who cross state linesAugust 23, 2024 | cbsnews.comNantHealth Achieves NCQA Accreditation in Utilization ManagementJune 12, 2024 | businesswire.com13 Most Romantic Getaways in New HampshireApril 23, 2024 | travel.usnews.comNantHealth Welcomes Marc Harrison as Chief Legal Officer to Executive TeamApril 23, 2024 | businesswire.comSee More Headlines NH Stock Analysis - Frequently Asked Questions How have NH shares performed this year? NantHealth's stock was trading at $0.43 at the beginning of 2024. Since then, NH stock has decreased by 95.3% and is now trading at $0.02. View the best growth stocks for 2024 here. How were NantHealth's earnings last quarter? NantHealth, Inc. (NASDAQ:NH) released its quarterly earnings data on Thursday, November, 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by $0.02. The firm earned $14.36 million during the quarter, compared to analysts' expectations of $17.70 million. When did NantHealth IPO? NantHealth (NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers. How do I buy shares of NantHealth? Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of NantHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK) and AbbVie (ABBV). Company Calendar Last Earnings11/04/2021Today9/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Data processing & preparation Sub-IndustryN/A Current SymbolNASDAQ:NH Previous SymbolNYSE:NH CUSIPN/A CIK1566469 Webwww.nanthealth.com Phone(855) 949-6268FaxN/AEmployees326Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($7.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-67,780,000.00 Net Margins-94.67% Pretax Margin-95.06% Return on EquityN/A Return on Assets-39.82% Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio0.64 Sales & Book Value Annual Sales$67.68 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($30.72) per share Price / Book0.00Miscellaneous Outstanding Shares7,703,000Free Float2,981,000Market Cap$154,060.00 OptionableNot Optionable Beta1.82 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report This page (NASDAQ:NH) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.